BiotechTube
Home/Bond Biosciences/Michael Beckloff
MB

Michael Beckloff

Director

Bond Biosciences

Therapeutic Areas

Hereditary HemochromatosisIon-Related Diseases

Bond Biosciences Pipeline

DrugIndicationPhase
BBI-001Hereditary Hemochromatosis (Iron Overload)Phase 1

Leadership Team at Bond Biosciences

CB
Cory Berkland, PhD
Chairman, Officer, Co-Founder
MR
Mike Riley, MSc, JD
Director, Officer, Corporate Secretary, Treasurer, Co-Founder
TO
Tim Opler, PhD
Director, Co-Founder
View full Bond Biosciences profile